Kim Janda - 31 Dec 2021 Form 5 Insider Report for Sorrento Therapeutics, Inc. (SRNEQ)

Role
Director
Signature
/s/ Henry Ji, Ph.D., as Attorney-in-Fact
Issuer symbol
SRNEQ
Transactions as of
31 Dec 2021
Net transactions value
-$31,273
Form type
5
Filing time
06 Feb 2023, 20:10:05 UTC
Previous filing
27 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SRNEQ Common Stock Sale $31,273 -3,000 -100% $10.42 0 15 Mar 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.